4//SEC Filing
RESPONSE BIOMEDICAL CORP 4
Accession 0001437749-15-005865
CIK 0000806888operating
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 8:17 PM ET
Size
7.0 KB
Accession
0001437749-15-005865
Insider Transaction Report
Form 4
HOLLER ANTHONY F
Director
Transactions
- Award
Common Stock
2015-03-19+21,843→ 58,342 total - Award
Stock Option (Right to Buy)
2015-03-19+5,000→ 5,000 totalExercise: $0.92Exp: 2025-03-19→ Common Stock (5,000 underlying)
Footnotes (3)
- [F1]100% of the restricted share units vested on the date of grant. The expiration date for each of the restricted share units will be the earlier of three (3) years after the effective date or two (2) years following the grantee's termination date. The reporting person has elected to defer receipt of the common stock underlying the restricted share units until a later date not to exceed the expiration date.
- [F2]Exercise prices shown are denominated in Canadian dollars.
- [F3]100% of the options vest on March 20, 2016, subject to the reporting person's continued service as a director of the Company through each vesting date.
Documents
Issuer
RESPONSE BIOMEDICAL CORP
CIK 0000806888
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0000806888
Filing Metadata
- Form type
- 4
- Filed
- Mar 22, 8:00 PM ET
- Accepted
- Mar 23, 8:17 PM ET
- Size
- 7.0 KB